Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of golimumab in active ankylosing spondylitis has completed, with results posted in 2009. The trial was sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Golimumab (Simponi) (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Spondylitis, Ankylosing | Phase 3 | Status: COMPLETED | Results posted: 2009-07-13